Gene · 51196
Papers2,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hiding in plain sight: genetics of childhood steroid-resistant nephrotic syndrome in Sub-Saharan Africa. | Pediatr Nephrol | 2023 | 36459247 | PubTator, text mining | PubMed |
| Outcomes and perception of cloud-based remote patient monitoring in children receiving automated peritoneal dialysis: a prospective study. | Pediatr Nephrol | 2023 | 36449100 | PubTator, text mining | PubMed |
| Cryptic mutations of PLC family members in brain disorders: recent discoveries and a deep-learning-based approach. | Brain | 2023 | 36448305 | PubTator, text mining | PubMed |
| Precision cut intestinal slices, a novel model of acute food allergic reactions. | Allergy | 2023 | 36377289 | PubTator, text mining | PubMed |
| Outcomes of steroid-resistant nephrotic syndrome in children not treated with intensified immunosuppression. | Pediatr Nephrol | 2023 | 36315273 | PubTator, text mining | PubMed |
| IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. | Pediatr Nephrol | 2023 | 36269406 | PubTator, text mining | PubMed |
| Kidney Organoids Generated Using an Allelic Series of NPHS2 Point Variants Reveal Distinct Intracellular Podocin Mistrafficking. | J Am Soc Nephrol | 2023 | 36167728 | PubTator, text mining | PubMed |
| Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions. | Pediatr Nephrol | 2023 | 35482099 | PubTator, text mining | PubMed |
| The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients. | J Cancer Res Clin Oncol | 2023 | 35220468 | PubTator, text mining | PubMed |
| Multi-ancestry meta-analysis of asthma identifies novel associations and highlights the value of increased power and diversity. | Cell Genom | 2022 | 36778051 | PubTator, text mining | PubMed |
| Global Biobank Meta-analysis Initiative: Powering genetic discovery across human disease. | Cell Genom | 2022 | 36777996 | PubTator, text mining | PubMed |
| Compound Homozygous Rare Mutations in PLCE1 and HPS1 Genes Associated with Autosomal Recessive Retinitis Pigmentosa in Pakistani Families. | Iran J Public Health | 2022 | 36743378 | PubTator, text mining | PubMed |
| Epigenetic modifications in esophageal cancer: An evolving biomarker. | Front Genet | 2022 | 36704345 | PubTator, text mining | PubMed |
| Plcz1 Deficiency Decreased Fertility in Male Mice Which Is Associated with Sperm Quality Decline and Abnormal Cytoskeleton in Epididymis. | Int J Mol Sci | 2022 | 36613757 | PubTator, text mining | PubMed |
| A fast lasso-based method for inferring higher-order interactions. | PLoS Comput Biol | 2022 | 36580499 | PubTator, text mining | PubMed |
| Polygenic Risk Score and Risk Factors for Preeclampsia and Gestational Hypertension. | J Pers Med | 2022 | 36579561 | PubTator, text mining | PubMed |
| Focal Segmental Glomerulosclerosis Followed by Granuloma and Preceding T-Cell Lymphoma by 46 Months: A Continuation Process or Coincidence. | Cureus | 2022 | 36579279 | PubTator, text mining | PubMed |
| Effects of Pre-Pregnancy Overweight/Obesity on the Pattern of Association of Hypertension Susceptibility Genes with Preeclampsia. | Life (Basel) | 2022 | 36556383 | PubTator, text mining | PubMed |
| The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy. | Int J Mol Sci | 2022 | 36555234 | PubTator, text mining | PubMed |
| Aggregation of Genome-Wide Association Data from FinnGen and UK Biobank Replicates Multiple Risk Loci for Pregnancy Complications. | Genes (Basel) | 2022 | 36553520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51196/papers?page=9